Related Experiment Video

Updated: Jul 13, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
12:28

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains

Published on: June 3, 2020

[Clinical characteristics, diagnostic criteria and treatment of progressive multifocal leukoencephalopathy]

Yasuo Kuroda1, Masafumi Kosugi

  • 1Department of Internal Medicine, Saga University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|August 19, 2007
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) requires early diagnosis and treatment for better outcomes. While advanced MRI and PCR diagnostics improve detection, managing immune reconstitution inflammatory syndrome in HIV-associated PML remains a challenge.

Area of Science:

  • Neuroscience
  • Virology
  • Immunology

Context:

  • Progressive multifocal leukoencephalopathy (PML) is a rare, severe demyelinating disease.
  • PML is caused by the John Cunningham virus (JCV) reactivating in immunocompromised individuals.
  • Early diagnosis and prompt treatment are crucial due to PML's rapid progression and poor prognosis.

Purpose:

  • To review the clinical characteristics, diagnostic criteria, and treatment of PML.
  • To highlight advancements in PML diagnosis and management.
  • To identify challenges in treating associated inflammatory syndromes.

Summary:

  • PML presents with rapid neurological decline, necessitating timely intervention.
  • Diffusion-weighted MRI and PCR detection of JCV-DNA in cerebrospinal fluid are key diagnostic tools, largely replacing brain biopsy.
  • Highly active antiretroviral therapy (HAART) improves survival and neurological function in HIV-associated PML.

Impact:

  • Improved diagnostic accuracy and speed for PML.
  • Enhanced patient outcomes for HIV-associated PML through HAART.
  • Identifies the unresolved challenge of managing immune reconstitution inflammatory syndrome (IRIS) in PML patients.

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

Mouse Models of Periventricular Leukomalacia06:24

Mouse Models of Periventricular Leukomalacia

Published on: May 18, 2010

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...